Antimicrobial peptide resistance mechanisms of human bacterial pathogens

Current Issues in Molecular Biology

Volumn 8, Issue 1, 2006, Pages 11-26

  Nizet, Victor ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIMICROBIAL CATIONIC PEPTIDE; BETA DEFENSIN; CATHELICIDIN; PROBIOTIC AGENT; PROTEINASE;

ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL SURFACE; DISEASE PREDISPOSITION; DISEASE RESISTANCE; DRUG MECHANISM; ENZYME SYNTHESIS; GENE THERAPY; IN VIVO STUDY; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PNEUMONIA; PROTEIN FUNCTION; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; SURFACE CHARGE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ADENOSINE MONOPHOSPHATE; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; OPPORTUNISTIC INFECTIONS; PEPTIDES; PROTEIN BINDING; VIRULENCE;

ADENOVIRIDAE; BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; MAMMALIA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS;

EID: 25144434489     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Abachin, E., Poyart, C., Pellegrini, E., Milohanic, E., Fiedler, F., Berche, P., and Trieu-Cuot, P. (2002). Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol. Microbiol. 43, 1-14.
2. Bader, M. W., Navarre, W. W., Shiau, W., Nikaido, H., Frye, J. G., McClelland, M., Fang, F. C., and Miller, S. I. (2003). Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol. Microbiol. 50, 219-230.
3. Bals, R., Wang, X., Zasloff, M., and Wilson, J. M. (1998). The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA. 95, 9541-9546.
4. Birchler, T., Seibl, R., Buchner, K., Loeliger, S., Seger, R., Hossle, J. P., Aguzzi, A., and Lauener, R. P. (2001). Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31, 3131-3137.
5. Boman, H. G., Agerberth, B., and Boman, A. (1993). Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61, 2978-2984.
6. Brodsky, I. E., Ernst, R. K., Miller, S. I., and Falkow, S. (2002). mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J. Bacteriol. 184, 3203-3213.
7. Brodsky, I. E., Ghori, N., Falkow, S., and Monack, D. (2005). Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol. Microbiol. 55, 954-972.
8. Brogden, K. A., Kalfa, V. C., Ackermann, M. R., Palmquist, D. E., McCray, P. B., Jr., and Tack, B. F. (2001). The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob. Agents Chemother. 45, 331-334.
9. Buchanan, J. T., Stannard, J., Lauth, X., Westerman, M., Ostland, V., Van Olst, J., Carlberg, J., and Nizet, V. (2005). Streptococcus iniae phosphoglucomutase is a virulence factor and target for vaccine development. Infect. Immun. (in press).
10. Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Alberti, S., and Bengoechea, J. A. (2004). Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72, 7107-7114.
11. Cao, M., and Helmann, J. D. (2004). The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J. Bacteriol. 186, 1136-1146.
12. Ceccarelli, A. V., Cole, A. M., Park, A. K., Tahk, S., Yoshioka, D., and Ganz, T. (2001). Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections. Comp. Med. 51, 75-79.
13. Chalekson, C. P., Neumeister, M. W., and Jaynes, J. (2002). Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plast. Reconstr. Surg. 109, 1338-1343.
14. Crouch, M. L., Becker, L. A., Bang, I. S., Tanabe, H., Ouellette, A. J., and Fang, F. C. (2005). The alternative sigma factor sigma is required for resistance of Salmonella enterica serovar Typhimurium to antimicrobial peptides. Mol. Microbiol. 56, 789-799.
15. Detweiler, C. S., Monack, D. M., Brodsky, I. E., Mathew, H., and Falkow, S. (2003). virK, somA and rcsC are important for systemic Salmonella enterica serovar Typhimurium infection and cationic peptide resistance. Mol. Microbiol. 48, 385-400.
16. Devine, D. A., Marsh, P. D., Percival, R. S., Rangarajan, M., and Curtis, M.A. (1999). Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp. Microbiology 145 (Pt 4), 965-971.
17. Di Nardo, A., Vitiello, A., and Gallo, R. L. (2003). Cutting edge: Mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278.
18. Dinulos, J. G., Mentele, L., Fredericks, L. P., Dale, B. A., and Darmstadt, G. L. (2003). Keratinocyte expression of human beta defensin 2 following bacterial infection: role in cutaneous host defense. Clin. Diagn. Lab. Immunol. 10, 161-166.
19. Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., and Gallo, R. L. (2001). Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91-97.
20. Dunman, P. M., Murphy, E., Haney, S., Palacios, D., Tucker-Kellogg, G., Wu, S., Brown, E. L., Zagursky, R. J., Shlaes, D., and Projan, S. J. (2001). Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183, 7341-7353.
21. Efstratiou, A. (2000). Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45 Suppl, 3-12.
22. Ernst, R. K., Guina, T., and Miller, S. I. (1999a). How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J. Infect. Dis. 179 Suppl 2, S326-330.
23. Ernst, R. K., Guina, T., and Miller, S. I. (2001). Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3, 1327-1334.
24. Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., and Miller, S. I. (1999b). Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565.
25. Frick, I. M., Akesson, P., Rasmussen, M., Schmidtchen, A., and Bjorck, L. (2003). SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 278, 16561-16566.
26. Gao, L. Y., Laval, F., Lawson, E. H., Groger, R. K., Woodruff, A., Morisaki, J. H., Cox, J. S., Daffe, M., and Brown, E. J. (2003). Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy. Mol. Microbiol. 49, 1547-1563.
27. Garcia Vescovi, E., Soncini, F. C., and Groisman, E. A. (1994). The role of the PhoP/PhoQ regulon in Salmonella virulence. Res. Microbiol. 145, 473-480.
28. Gionchetti, P., Amadini, C., Rizzello, F., Venturi, A., Palmonari, V., Morselli, C., Romagnoli, R., and Campieri, M. (2002). Probiotics - role in inflammatory bowel disease. Dig. Liver. Dis. 34 Suppl 2, S58-62.
29. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., and Wilson, J. M. (1997). Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560.
30. Guina, T., Yi, E. C., Wang, H., Hackett, M., and Miller, S. I. (2000). A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 182, 4077-4086.
31. Gunn, J. S. (2001). Bacterial modification of LPS and resistance to antimicrobial peptides. J. Endotoxin Res. 7, 57-62.
32. Gunn, J. S., Ryan, S. S., Van Velkinburgh, J. C., Ernst, R. K., and Miller, S. I. (2000). Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect. Immun. 68, 6139-6146.
33. Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., and Miller, S. I. (1998). Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95, 189-198.
34. Gutsmann, T., Hagge, S. O., Larrick, J. W., Seydel, U., and Wiese, A. (2001). Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys. J. 80, 2935-2945.
35. Hamilton, A., Mertz, R. H., Needham, R. H. V., Lauth, X., Nizet, V., and Jones, A. L. (2004). Evasion of innate immunity: A novel function for GBS penicillin-binding protein 1a. Paper presented at: American Society for Microbiology General Meeting (New Orleans, LA).
36. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., and Stahle-Backdahl, M. (2003). The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
37. Hidalgo-Grass, C., Dan-Goor, M., Maly, A., Eran, Y., Kwinn, L. A., Nizet, V., Ravins, M., Jaffe, J., Peyser, A., Moses, A. E., and Hanski, E. (2004). Effect of a bacterial pheromone peptide on host chemokine degradation in group A streptococcal necrotising soft-tissue infection. Lancet 362, 696-703.
38. Hill, H. R., Bohnsack, J. F., Morris, E. Z., Augustine, N. H., Parker, C. J., Cleary, P. P., and Wu, J. T. (1988). Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J. Immunol. 141, 3551-3556.
39. Hooper, L. V., Stappenbeck, T. S., Hong, C. V., and Gordon, J. I. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269-273.
40. Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y., Eckmann, L., and Kagnoff, M. F. (2005). Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174, 4901-4907.
41. Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., and Gudmundsson, G. (2001). Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7, 180-185.
42. Jerse, A. E., Sharma, N. D., Simms, A. N., Crow, E. T., Snyder, L. A., and Shafer, W. M. (2003). A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 71, 5576-5582.
43. Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., and Tarkowski, A. (2004). Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172, 1169-1176.
44. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., and Flavell, R. A. (2005). Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
45. Kristian, S. A., Durr, M., Van Strijp, J. A., Neumeister, B., and Peschel, A. (2003a). MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect. Immun. 71, 546-549.
46. Kristian, S. A., Lauth, X., Nizet, V., Goetz, F., Neumeister, B., Peschel, A., and Landmann, R. (2003b). Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J. Infect. Dis. 188, 414-423.
47. Kupferwasser, L. I., Skurray, R. A., Brown, M. H., Firth, N., Yeaman, M. R., and Bayer, A. S. (1999). Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of the qacA locus. Antimicrob. Agents Chemother. 43, 2395-2399.
48. Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y. C., Braun, J., and Targan, S. R. (2002). Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 123, 689-699.
49. Lauth, X., McNamara, C. W., Myskowski, S., Igwe, E., Beall, B., Ghosh, P., Gallo, R. L., and Nizet, V. (2004). A new virulence role for group A streptococcal M1 protein is protection against cathelicidin antimicrobial peptides. Paper presented at: American Society for Microbiology General Meeting (New Orleans, LA).
50. Lee, P. H., Ohtake, T., Zaiou, M., Murakami, M., Rudisill, J. A., Lin, K. H., Gallo R. L. (2005) Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. USA. 102, 3750-3755.
51. Levy, S. B. (2002). Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92 Suppl, 65S-71S.
52. Liu, L., Roberts, A. A., and Ganz, T. (2003). By IL1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170, 575-580.
53. Lopez-Solanilla, E., Gonzalez-Zorn, B., Novella, S., Vazquez-Boland, J. A., and Rodriguez-Palenzuela, P. (2003). Susceptibility of Listeria monocytogenes to antimicrobial peptides. FEMS Microbiol. Lett. 226, 101-105.
54. Lushbaugh, W. B., Blossom, A. C., Shah, P. H., Banga, A. K., Jaynes, J. M., Cleary, J. D., and Finley, R. W. (2000). Use of intravaginal microbicides to prevent acquisition of Trichomonas vaginalis infection in Lactobacillus-pretreated, estrogenized young mice. Am. J. Trop. Med. Hyg. 63, 284-289.
55. Lysenko, E. S., Gould, J., Bals, R., Wilson, J. M., and Weiser, J. N. (2000). Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68, 1664-1671.
56. Macfarlane, E. L., Kwasnicka, A., and Hancock, R. E. (2000). Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146 (Pt 10), 2543-2554.
57. Marceau, M., Sebbane, F., Collyn, F., and Simonet, M. (2003). Function and regulation of the Salmonella-like pmrF antimicrobial peptide resistance operon in Yersinia pseudotuberculosis. Adv. Exp. Med. Biol. 529, 253-256.
58. Mason, K. M., Munson, R. S., Jr., and Bakaletz, L. O. (2005). A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect. Immun. 73, 599-608.
59. McCoy, A. J., Liu, H., Falla, T. J., and Gunn, J. S. (2001). Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob. Agents Chemother. 45, 2030-2037.
60. McPhee, J. B., Lewenza, S., and Hancock, R. E. (2003). Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205-217.
61. Morrison, G., Kilanowski, F., Davidson, D., and Dorin, J. (2002). Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect. Immun. 70, 3053-3060.
62. Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N., and Wilson, J. M. (2002). beta-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068-3072.
63. Moskowitz, S. M., Ernst, R. K., and Miller, S. I. (2004). PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186, 575-579.
64. Naser, S. A., Ghobrial, G., Romero, C., and Valentine, J. F. (2004). Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 364, 1039-1044.
65. Nishi, H., Komatsuzawa, H., Fujiwara, T., McCallum, N., and Sugai, M. (2004). Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob. Agents Chemother. 48, 4800-4807.
66. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., and Gallo, R. L. (2001). Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
67. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., and Leung, D. Y. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
68. Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B., and Shai, Y. (1999). Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341 (Pt 3), 501-513.
69. Park, P. W., Pier, G. B., Hinkes, M. T., and Bernfield, M. (2001). Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411, 98-102.
70. Park, P. W., Pier, G. B., Preston, M. J., Goldberger, O., Fitzgerald, M. L., and Bernfield, M. (2000). Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J. Biol. Chem. 275, 3057-3064.
71. Parra-Lopez, C., Lin, R., Aspedon, A., and Groisman, E. A. (1994). A Salmonella protein that is required for resistance to antimicrobial peptides and transport of potassium. EMBO. J. 13, 3964-3972.
72. Peschel, A. (2002). How do bacteria resist human antimicrobial peptides? Trends Microbiol 10, 179-186.
73. Peschel, A., and Collins, L. V. (2001). Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 22, 1651-1659.
74. Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001). Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with I-lysine. J. Exp. Med. 193, 1067-1076.
75. Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., and Gotz, F. (1999). Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405-8410.
76. Poyart, C., Pellegrini, E., Marceau, M., Baptista, M., Jaubert, F., Lamy, M. C., and Trieu-Cuot, P. (2003). Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 49, 1615-1625.
77. Putsep, K., Carlsson, G., Boman, H. G., and Andersson, M. (2002). Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149.
78. Robey, M., O'Connell, W., and Cianciotto, N. P. (2001). Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect. Immun. 69, 4276-4286.
79. Rosenberger, C. M., Gallo, R. L., and Finlay, B. B. (2004). Interplay between antibacterial effectors: A macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA. 101, 2422-2427.
80. Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., and Bevins, C. L. (2003). Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 42, 522-526.
81. Sawamura, D., Goto, M., Shibaki, A., Akiyama, M., McMillan, J. R., Abiko, Y., and Shimizu, H. (2005). Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection. Gene. Ther. 12, 857-861.
82. Schmidtchen, A., Frick, I. M., Andersson, E., Tapper, H., and Bjorck, L. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46, 157-168.
83. Schmidtchen, A., Frick, I. M., and Bjorck, L. (2001). Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol. 39, 708-713.
84. Shafer, W. M., Qu, X., Waring, A. J., and Lehrer, R. I. (1998). Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA. 95, 1829-1833.
85. Shelburne, C. E., Coulter, W. A., Olguin, D., Lantz, M. S., and Lopatin, D. E. (2005). Induction of β-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob. Agents Chemother. 49, 183-187.
86. Shinnar, A. E., Butler, K. L., and Park, H. J. (2003). Cathelicidin family of antimicrobial peptides: proteolytic processing and protease resistance. Bioorg. Chem. 31, 425-436.
87. Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wojcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004). Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48, 4673-4679.
88. Smith, J. J., Travis, S. M., Greenberg, E. P., and Welsh, M. J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
89. Starner, T. D., Swords, W. E., Apicella, M. A., and McCray, P. B., Jr. (2002). Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect. Immun. 70, 5287-5289.
90. Staubitz, P., Neumann, H., Schneider, T., Wiedemann, I., and Peschel, A. (2004). MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol. Lett. 231, 67-71.
91. Taggart, C. C., Greene, C. M., Smith, S. G., Levine, R. L., McCray, P. B., Jr., O'Neill, S., and McElvaney, N. G. (2003). Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J. Immunol. 171, 931-937.
92. Tomasinsig, L., Scocchi, M., Di Loreto, C., Artico, D., and Zanetti, M. (2002). Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J. Leukoc. Biol. 72, 1003-1010.
93. Ulvatne, H., Haukland, H. H., Samuelsen, O., Kramer, M., and Vorland, L. H. (2002). Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B. J.Antimicrob. Chemother. 50, 461-467.
94. Veal, W. L., Nicholas, R. A., and Shafer, W. M. (2002). Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J. Bacteriol. 184, 5619-5624.
95. Wang, X., Zhang, Z., Louboutin, J. P., Moser, C., Weiner, D. J., and Wilson, J. M. (2003). Airway epithelia regulate expression of human beta-defensin 2 through Toll-like receptor 2. FASEB. J. 17, 1727-1729.
96. Wehkamp, J., Schmid, M., Fellermann, K., and Stange, E. F. (2005). Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukoc. Biol. 77, 460-465.
97. Weiser, J. N., Bae, D., Fasching, C., Scamurra, R. W., Ratner, A. J., and Janoff, E. N. (2003). Antibody enhanced pneumococcal adherence requires IgA1 protease. Proc. Natl. Acad. Sci. USA. 100, 4215-4220.
98. West, N. P., Jungnitz, H., Fitter, J. T., McArthur, J. D., Guzman, C. A., and Walker, M. J. (2000). Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect. Immun. 68, 4673-4680.
99. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., and Parks, W. C. (1999). Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117.
100. Wu, H., Zhang, G., Minton, J. E., Ross, C. R., and Blecha, F. (2000). Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect. Immun. 68, 5552-5558.
101. Zgurskaya, H. I. (2002). Molecular analysis of efflux pump-based antibiotic resistance. Int. J. Med. Microbiol. 292, 95-105.